Cephalosporin acetylhydrolase gene and protein encoded by said gene
CA 2040707 C · Owner: Yagi, Shigeo · Inventors: Mitsushima, Kenji; Sonoyama, Takayasu; Yagi, Shigeo
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a cephalosporin acetylhydrolase gene, a recombinant DNA molecule prepared by introducing the gene into a vector used in an E. coli host-vector system E. coli cells transformed with the recombinant DNA molecule a, protein having the amino acid sequence encoded by the gene an, enzyme which is a multimer of the protein and a process for, preparing the protein or enzyme. The cephalosporin acetylhydrolase is an enzyme useful for converting cephalosporins, e.g. cephalosporin C and 7-ACA into, deacetylated ones, e.g. deacetylcephalosporin C and deacetyl 7-ACA, which are useful as intermediates in the preparation of a variety of derivatized cephalosporin antibiotics.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 17, 1991 and granted July 9, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 17, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 17, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.